HK1155739A1 - A benzimidazole derivative as a calcium channel blocker - Google Patents
A benzimidazole derivative as a calcium channel blockerInfo
- Publication number
- HK1155739A1 HK1155739A1 HK11109943.6A HK11109943A HK1155739A1 HK 1155739 A1 HK1155739 A1 HK 1155739A1 HK 11109943 A HK11109943 A HK 11109943A HK 1155739 A1 HK1155739 A1 HK 1155739A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- calcium channel
- channel blocker
- alkyl
- compounds
- benzimidazole derivative
- Prior art date
Links
- 229940127291 Calcium channel antagonist Drugs 0.000 title abstract 2
- 239000000480 calcium channel blocker Substances 0.000 title abstract 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2008051602 | 2008-04-25 | ||
| PCT/IB2009/051668 WO2009130679A1 (en) | 2008-04-25 | 2009-04-23 | Benzimidazole derivatives as calcium channel blockers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1155739A1 true HK1155739A1 (en) | 2012-05-25 |
Family
ID=40823387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11109943.6A HK1155739A1 (en) | 2008-04-25 | 2011-09-21 | A benzimidazole derivative as a calcium channel blocker |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20110039905A1 (pt) |
| EP (1) | EP2271628A1 (pt) |
| JP (1) | JP4806734B2 (pt) |
| KR (1) | KR101364909B1 (pt) |
| CN (1) | CN102015658B (pt) |
| AR (1) | AR071217A1 (pt) |
| AU (1) | AU2009239620A1 (pt) |
| BR (1) | BRPI0911538B1 (pt) |
| CA (1) | CA2722067A1 (pt) |
| HK (1) | HK1155739A1 (pt) |
| IL (1) | IL208856A0 (pt) |
| MX (1) | MX2010011459A (pt) |
| NZ (1) | NZ589509A (pt) |
| RU (1) | RU2478095C2 (pt) |
| TW (1) | TWI401249B (pt) |
| WO (1) | WO2009130679A1 (pt) |
| ZA (1) | ZA201008448B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008132679A1 (en) | 2007-04-27 | 2008-11-06 | Actelion Pharmaceuticals Ltd | Bridged six-membered ring compounds |
| KR20110079736A (ko) | 2008-10-22 | 2011-07-07 | 액테리온 파마슈티칼 리미티드 | 가교된 테트라하이드로나프탈렌 유도체 |
| AU2009306002B2 (en) * | 2008-10-22 | 2015-01-15 | Idorsia Pharmaceuticals Ltd | Salts of isobutyric acid (1 R*, 2R*, 4R* ) -2- (2-{ [3- (4, 7-dimethoxy-1 H-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl ester |
| WO2010046729A2 (en) * | 2008-10-23 | 2010-04-29 | Actelion Pharmaceuticals Ltd | Tetrahydronaphthalene compounds |
| JP5909237B2 (ja) | 2010-10-20 | 2016-04-26 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ビシクロ［２．２．２］オクタン−２−オン化合物の製造 |
| WO2012052943A1 (en) | 2010-10-20 | 2012-04-26 | Actelion Pharmaceuticals Ltd | Diastereoselective preparation of bicyclo[2.2.2]octan-2-one compounds |
| JP6500201B2 (ja) * | 2014-05-28 | 2019-04-17 | トーアエイヨー株式会社 | 置換トロパン誘導体 |
| AU2020311942A1 (en) | 2019-07-11 | 2022-02-24 | Praxis Precision Medicines, Inc. | Formulations of T-type calcium channel modulators and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1319144C (en) * | 1986-11-14 | 1993-06-15 | Quirico Branca | Tetrahydronaphthalene derivatives |
| US6268377B1 (en) * | 1998-09-28 | 2001-07-31 | Merck & Co., Inc. | Method for treating androgen-related conditions |
| EP1438297A1 (en) | 2001-10-10 | 2004-07-21 | Aryx Therapeutics | Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina |
| WO2008132679A1 (en) * | 2007-04-27 | 2008-11-06 | Actelion Pharmaceuticals Ltd | Bridged six-membered ring compounds |
-
2009
- 2009-04-23 CA CA2722067A patent/CA2722067A1/en not_active Abandoned
- 2009-04-23 RU RU2010147865/04A patent/RU2478095C2/ru active
- 2009-04-23 CN CN2009801155609A patent/CN102015658B/zh not_active Expired - Fee Related
- 2009-04-23 WO PCT/IB2009/051668 patent/WO2009130679A1/en active Application Filing
- 2009-04-23 NZ NZ589509A patent/NZ589509A/en not_active IP Right Cessation
- 2009-04-23 KR KR1020107026438A patent/KR101364909B1/ko active IP Right Grant
- 2009-04-23 BR BRPI0911538-2A patent/BRPI0911538B1/pt not_active IP Right Cessation
- 2009-04-23 US US12/989,443 patent/US20110039905A1/en not_active Abandoned
- 2009-04-23 EP EP09734909A patent/EP2271628A1/en not_active Withdrawn
- 2009-04-23 AU AU2009239620A patent/AU2009239620A1/en not_active Abandoned
- 2009-04-23 MX MX2010011459A patent/MX2010011459A/es active IP Right Grant
- 2009-04-23 JP JP2011505634A patent/JP4806734B2/ja not_active Expired - Fee Related
- 2009-04-24 AR ARP090101462A patent/AR071217A1/es unknown
- 2009-04-24 TW TW098113755A patent/TWI401249B/zh not_active IP Right Cessation
-
2010
- 2010-10-21 IL IL208856A patent/IL208856A0/en unknown
- 2010-11-24 ZA ZA2010/08448A patent/ZA201008448B/en unknown
-
2011
- 2011-09-21 HK HK11109943.6A patent/HK1155739A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110011639A (ko) | 2011-02-08 |
| TW200944507A (en) | 2009-11-01 |
| BRPI0911538B1 (pt) | 2021-05-18 |
| NZ589509A (en) | 2012-07-27 |
| TWI401249B (zh) | 2013-07-11 |
| CN102015658A (zh) | 2011-04-13 |
| BRPI0911538A2 (pt) | 2020-01-07 |
| CN102015658B (zh) | 2013-03-20 |
| ZA201008448B (en) | 2012-04-25 |
| RU2478095C2 (ru) | 2013-03-27 |
| IL208856A0 (en) | 2011-01-31 |
| JP2011518821A (ja) | 2011-06-30 |
| CA2722067A1 (en) | 2009-10-29 |
| EP2271628A1 (en) | 2011-01-12 |
| JP4806734B2 (ja) | 2011-11-02 |
| KR101364909B1 (ko) | 2014-02-21 |
| WO2009130679A1 (en) | 2009-10-29 |
| MX2010011459A (es) | 2010-11-12 |
| AU2009239620A1 (en) | 2009-10-29 |
| RU2010147865A (ru) | 2012-05-27 |
| AR071217A1 (es) | 2010-06-02 |
| US20110039905A1 (en) | 2011-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1155739A1 (en) | A benzimidazole derivative as a calcium channel blocker | |
| CY1120477T1 (el) | Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων | |
| MA35452B1 (fr) | 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante | |
| PE20130155A1 (es) | Derivados de ariletinilo | |
| MY144971A (en) | Prodrug of cinnamide compound | |
| RS54369B1 (en) | NEW QUINOLINE COMPOUNDS SUBSTITUTED AS S-NITROSOGLUTATHION REDUCTASE INHIBITORS | |
| NZ592497A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| EA201490550A1 (ru) | Способ синтеза и промежуточные соединения | |
| JO2947B1 (en) | Compounds corresponding to cyclopamine | |
| EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
| MA34389B1 (fr) | Nouvelles aminopyrazoloquinazolines | |
| UA108760C2 (uk) | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
| WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
| MX2015007883A (es) | Compuestos para protección de células. | |
| TN2009000287A1 (en) | Cyclized derivatives as eg-5inhibitors | |
| MY149400A (en) | Bridged six-membered ring compounds | |
| MA35086B1 (fr) | Compose de triazolopyridine | |
| EA200970793A1 (ru) | Модуляторы рецепторов, активируемых пролифераторами пероксисом | |
| MX2013006811A (es) | Compuestos, composiciones y articulos fotocromaticos. | |
| AR060379A1 (es) | Compuesto y composicion herbicida | |
| RS54248B1 (en) | NEW UNITS AS LISTS OF HISTAMINE H3 RECEPTORS | |
| MX2009008028A (es) | Agentes antiparasitarios. | |
| MY161992A (en) | Novel tetrahydroisoquinoline derivative | |
| UA111950C2 (uk) | Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну | |
| IN2012DN01251A (pt) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230423 |